WOONSOCKET, R.I., Dec. 7, 2011 /PRNewswire/ -- CVS Caremark Corporation (NYSE:CVS) will hold its annual Analyst Day in New York City on Tuesday, December 20, 2011, beginning at 8:00 a.m. (EST). Senior members of the CVS Caremark leadership team will present an overview of their strategies to drive long-term growth and shareholder value. The Company will also provide initial 2012 earnings guidance at the event.
(Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO )
A live webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Caremark web site for all interested parties. Presentations and supplemental slides will also be available on the web site. To access the webcast or an archive of the event, visit http://info.cvscaremark.com/investors.
About the Company:
CVS Caremark is the largest pharmacy health care provider in the United States with integrated offerings across the entire spectrum of pharmacy care. We are uniquely positioned to engage plan members in behaviors that improve their health and to lower overall health care costs for health plans, plan sponsors and their members. CVS Caremark is a market leader in mail order pharmacy, retail pharmacy, specialty pharmacy, and retail clinics, and is a leading provider of Medicare Part D Prescription Drug Plans. As one of the country's largest pharmacy benefits managers (PBMs), we provide access to a network of more than 65,000 pharmacies, including more than 7,300 CVS/pharmacy® stores that provide unparalleled service and capabilities. Our clinical offerings include our signature Pharmacy Advisor™ program as well as innovative generic step therapy and genetic benefit management programs that promote more cost effective and healthier behaviors and improve health care outcomes. General information about CVS Caremark is available through the Company's website at http://info.cvscaremark.com.
SOURCE CVS Caremark Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article